Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (11): 1135-1139.DOI: 10.3969/j.issn.1673-8640.2021.11.009
Previous Articles Next Articles
HUANG Yao1, ZHANG Xiuling1, WANG Yan1, KONG Guimei2, XU Qin1()
Received:
2020-08-30
Online:
2021-11-30
Published:
2021-12-20
Contact:
XU Qin
CLC Number:
HUANG Yao, ZHANG Xiuling, WANG Yan, KONG Guimei, XU Qin. Respiratory tract virus surveillance and analysis of pneumonia inpatients from 2017 to 2020 in Yangzhou[J]. Laboratory Medicine, 2021, 36(11): 1135-1139.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.11.009
哨点医院 | 2017年 | 2018年 | 2019年 | 2020年 | 合计 |
---|---|---|---|---|---|
江苏省苏北人民医院 | 114 | 110 | 127 | 162 | 513 |
扬州大学附属医院 | 104 | 107 | 107 | 160 | 478 |
高邮市人民医院 | 108 | 104 | 110 | 149 | 471 |
扬州市第二人民医院(临时) | 17 | 17 | |||
合计 | 343 | 321 | 344 | 471 | 1 479 |
哨点医院 | 2017年 | 2018年 | 2019年 | 2020年 | 合计 |
---|---|---|---|---|---|
江苏省苏北人民医院 | 114 | 110 | 127 | 162 | 513 |
扬州大学附属医院 | 104 | 107 | 107 | 160 | 478 |
高邮市人民医院 | 108 | 104 | 110 | 149 | 471 |
扬州市第二人民医院(临时) | 17 | 17 | |||
合计 | 343 | 321 | 344 | 471 | 1 479 |
病毒名称 | 检出例数 | 检出率/% |
---|---|---|
流感病毒 | ||
新甲型H1N1 | 35 | 2.36 |
季节性H3N2 | 12 | 0.81 |
人禽流感H7N9 | 2 | 0.14 |
B型Victoria | 28 | 1.89 |
B型Yamagata | 5 | 0.34 |
人腺病毒 | 15 | 1.01 |
呼吸道合胞病毒 | 39 | 2.63 |
人肠道病毒 | 28 | 1.89 |
人副流感病毒 Ⅲ型 | 24 | 1.62 |
人腺病毒+人肠道病毒 | 2 | 0.14 |
人副流感病毒Ⅲ型+ 人肠道病毒 | 1 | 0.07 |
呼吸道合胞病毒+人肠道病毒 | 2 | 0.14 |
呼吸道合胞病毒+人副流感病毒Ⅲ型 | 2 | 0.14 |
合计 | 195 | 13.18 |
病毒名称 | 检出例数 | 检出率/% |
---|---|---|
流感病毒 | ||
新甲型H1N1 | 35 | 2.36 |
季节性H3N2 | 12 | 0.81 |
人禽流感H7N9 | 2 | 0.14 |
B型Victoria | 28 | 1.89 |
B型Yamagata | 5 | 0.34 |
人腺病毒 | 15 | 1.01 |
呼吸道合胞病毒 | 39 | 2.63 |
人肠道病毒 | 28 | 1.89 |
人副流感病毒 Ⅲ型 | 24 | 1.62 |
人腺病毒+人肠道病毒 | 2 | 0.14 |
人副流感病毒Ⅲ型+ 人肠道病毒 | 1 | 0.07 |
呼吸道合胞病毒+人肠道病毒 | 2 | 0.14 |
呼吸道合胞病毒+人副流感病毒Ⅲ型 | 2 | 0.14 |
合计 | 195 | 13.18 |
年份 | 流感病毒 | 人腺病毒 | 呼吸道合胞病毒 | 人副流感病毒Ⅲ型 | 人肠道 病毒 | 混合 感染 | 合计 | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
新甲型H1N1 | H3N2 | H7N9 | B型 Victoria | B型 Yamagata | |||||||
2017年 | 10(14.71) | 7(10.29) | 2(2.94) | 18(26.47) | 7(10.29) | 11(16.18) | 1 (1.47) | 11(16.18) | 1(1.47) | 68(100.00) | |
2018年 | 2 (4.65) | 4 (9.30) | 2 (4.65) | 11(25.58) | 6(13.95) | 14(32.56) | 4(9.30) | 43(100.00) | |||
2019年 | 23(38.33) | 4 (6.67) | 9(15.00) | 1 (1.67) | 3 (5.0) | 8(13.33) | 8(13.33) | 2 (3.33) | 2(3.33) | 60(100.00) | |
2020年 | 0 | 1 (4.17) | 1 (4.17) | 3(12.50) | 9(37.50) | 9(37.50) | 1 (4.17) | 24(100.00) | |||
合计 | 35(17.95) | 12(6.15) | 2(1.03) | 28(14.36) | 5 (2.56) | 15(7.69) | 39(20.00) | 24(12.31) | 28(14.36) | 7(3.58) | 195(100.00) |
年份 | 流感病毒 | 人腺病毒 | 呼吸道合胞病毒 | 人副流感病毒Ⅲ型 | 人肠道 病毒 | 混合 感染 | 合计 | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
新甲型H1N1 | H3N2 | H7N9 | B型 Victoria | B型 Yamagata | |||||||
2017年 | 10(14.71) | 7(10.29) | 2(2.94) | 18(26.47) | 7(10.29) | 11(16.18) | 1 (1.47) | 11(16.18) | 1(1.47) | 68(100.00) | |
2018年 | 2 (4.65) | 4 (9.30) | 2 (4.65) | 11(25.58) | 6(13.95) | 14(32.56) | 4(9.30) | 43(100.00) | |||
2019年 | 23(38.33) | 4 (6.67) | 9(15.00) | 1 (1.67) | 3 (5.0) | 8(13.33) | 8(13.33) | 2 (3.33) | 2(3.33) | 60(100.00) | |
2020年 | 0 | 1 (4.17) | 1 (4.17) | 3(12.50) | 9(37.50) | 9(37.50) | 1 (4.17) | 24(100.00) | |||
合计 | 35(17.95) | 12(6.15) | 2(1.03) | 28(14.36) | 5 (2.56) | 15(7.69) | 39(20.00) | 24(12.31) | 28(14.36) | 7(3.58) | 195(100.00) |
年龄/岁 | 流感病毒 | 人腺病毒 | 呼吸道合胞 病毒 | 人副流感病毒 Ⅲ型 | 人肠道病毒 | 混合感染 | 合计 |
---|---|---|---|---|---|---|---|
0~6 | 23(25.56) | 10(11.11) | 23(25.56) | 12(13.33) | 17(18.89) | 5(5.56) | 90(100.00) |
7~18 | 8(44.44) | 1(5.56) | 3(16.67) | 2(11.11) | 2(11.11) | 2(11.11) | 18(100.00) |
19~59 | 26(59.09) | 2(4.55) | 6(13.64) | 4(9.09) | 6(13.64) | 44(100.00) | |
≥60 | 25(58.14) | 2(4.65) | 7(16.28) | 6(13.95) | 3(6.98) | 43(100.00) | |
合计 | 82(42.05) | 15(7.69) | 39(20.00) | 24(12.31) | 28(14.36) | 7(3.58) | 195(100) |
年龄/岁 | 流感病毒 | 人腺病毒 | 呼吸道合胞 病毒 | 人副流感病毒 Ⅲ型 | 人肠道病毒 | 混合感染 | 合计 |
---|---|---|---|---|---|---|---|
0~6 | 23(25.56) | 10(11.11) | 23(25.56) | 12(13.33) | 17(18.89) | 5(5.56) | 90(100.00) |
7~18 | 8(44.44) | 1(5.56) | 3(16.67) | 2(11.11) | 2(11.11) | 2(11.11) | 18(100.00) |
19~59 | 26(59.09) | 2(4.55) | 6(13.64) | 4(9.09) | 6(13.64) | 44(100.00) | |
≥60 | 25(58.14) | 2(4.65) | 7(16.28) | 6(13.95) | 3(6.98) | 43(100.00) | |
合计 | 82(42.05) | 15(7.69) | 39(20.00) | 24(12.31) | 28(14.36) | 7(3.58) | 195(100) |
[1] |
MAHONY J B. Detection of respiratory viruses by molecular methods[J]. Clin Microbiol Rev, 2008, 21(4):716-747.
DOI URL |
[2] |
SETO W H, CONLY J M, PESSOA-SILVA C L, et al. Infection prevention and control measures for acute respiratory infections in healthcare settings:an update[J]. East Mediterr Health J, 2013, 19(Suppl 1):S39-S47.
DOI URL |
[3] |
HUI D S. Epidemic and emerging coronaviruses(severe acute respiratory syndrome and middle east respiratory syndrome)[J]. Clin Chest Med, 2017, 38(1):71-86.
DOI URL |
[4] |
RICCIONI G, DI PIETRO V, STANISCIA T, et al. Community acquired pneumonia in internal medicine:a one-year retrospective study based on pneumonia severity index[J]. Int J Immunopathol Pharmacol, 2005, 18(3):575-586.
DOI URL |
[5] |
WYLIE K M. The virome of the human respiratory tract[J]. Clin Chest Med, 2017, 38(1):11-19.
DOI URL |
[6] |
PRAT C, LACOMA A. Bacteria in the respiratory tract-how to treat? Or do not treat?[J]. Int J Infect Dis, 2016, 51:113-122.
DOI URL |
[7] |
TROY N M, BOSCO A. Respiratory viral infections and host responses;insights from genomics[J]. Respiratory Res, 2016, 17(1):156.
DOI URL |
[8] | 谢立, 杨旭辉, 陈恩富. 腺病毒感染研究进展[J]. 浙江预防医学, 2015, 27(3):262-265. |
[9] |
SHAH R D, WUNDERINK R G. Viral pneumonia and acute respiratory distress syndrome[J]. Clin Chest Med, 2017, 38(1):113-125.
DOI URL |
[10] | TAN J W, NURYASMIN R, APANDI Y, et al. Epidemiological and clinical features of enteroviral acute lower respiratory tract infections in hospitalized paediatric patients in a Malaysian tertiary center[J]. Med J Malaysia, 2016, 71(5):264-268. |
[11] | 向星宇, 张红, 高立冬, 等. 湖南省2012—2014年发热呼吸道症候群哨点监测结果及分析[J]. 实用预防医学, 2016, 23(12):1419-1423. |
[12] | 何静, 龚燕. 2009—2010年上海地区急性呼吸道感染病毒病原谱分析[J]. 微生物与感染, 2011, 6(2):90-96. |
[13] | 曹淑彦, 陈小方, 蔡晓红, 等. 温州地区2005—2006年急性呼吸道感染患儿病毒病原学检测的情况[J]. 实用儿科临床杂志, 2007, 22(16):1234-1235. |
[14] | 许爽, 祝洪珍, 李静, 等. 长春地区冬季儿童上呼吸道感染病毒病原学检测结果分析[J]. 中国卫生工程学, 2011, 10(3):227-229. |
[15] | 卢爱桃, 海岩, 跃华, 等. 呼和浩特地区呼吸道腺病毒感染情况调查分析[J]. 中国卫生检验杂志, 2014, 24(12):1785-1787. |
[16] |
CILLA G, OÑATE E, PEREZ-YARZA E G, et al. Viruses in community-acquired pneumonia in children aged less than 3 years old:high rate of viral coinfection[J]. J Med Virol, 2008, 80(10):1843-1849.
DOI URL |
[17] | 李军, 朱启镕, 余蕙, 等. 上海地区儿童急性下呼吸道常见病毒及鼻病毒感染的临床研究[J]. 临床儿科杂志, 2007, 25(6):457-461. |
[18] | 彭质斌, 许军, 余昭, 等. 中国10省(市)2009—2014年15岁以下儿童流感确诊住院病例严重急性呼吸道感染临床特征及其危险因素分析[J]. 中华流行病学杂志, 2015, 36(3):210-215. |
[19] | PRAT C, LACOMA A. Bacteria in the respiratory tract-how to treat? Or do not treat? International journal of infectious diseases:[J]. D:official publication of the International Society for Infectious Diseases, 2016, 51:113-22. |
[20] | NYE S, WHITLEY R J, KONG M. Viral infection in the development and progression of pediatric acute respiratory distress syndrome[J]. Front Pediatr, 2016, 4:128. |
[1] | WANG Huiying, TANG Yu, DONG Lili, WANG Jing. Role of Mycoplasma pneumoniae RNA determination in diagnosis and efficacy monitoring of pneumonia in children [J]. Laboratory Medicine, 2023, 38(9): 865-869. |
[2] | CHEN Danyang, ZHENG Siyu, ZHENG Ruilin, SU Jingyao, ZHU Bing, LI Yinghua. Research progress in influenza viruses [J]. Laboratory Medicine, 2023, 38(7): 696-703. |
[3] | ZHU Yurong, ZHANG Dan, HE Yaxing, LI Jingjing, HUANG Jing, LI Ting, LIU Peng, LIU Ronghua. Classification and epidemiology characteristics of Klebsiella pneumoniae isolated from clinic [J]. Laboratory Medicine, 2023, 38(5): 435-440. |
[4] | WANG Jiawei, ZHU Weinan, CHEN Yingying, JI Ping, WANG Ying. Clinical characteristics,molecular typing and drug resistance genes of carbapenem-resistant Klebsiella pneumoniae isolated from blood culturing [J]. Laboratory Medicine, 2023, 38(4): 362-367. |
[5] | WANG Yaling, HUANG Yunli, TIAN Mi, WANG Shunlan, XIAO Li. Relationship between EOS%,CCR3,eotaxin and disease severity in children with acute bronchopneumonia [J]. Laboratory Medicine, 2023, 38(3): 230-234. |
[6] | MA Kaihui, LÜ Zhi, ZHOU Yanyan, SU Jianrong. Characteristic analysis of Clostridium difficile colonization and infection in inpatients [J]. Laboratory Medicine, 2023, 38(2): 153-156. |
[7] | DENG Chen, DAI Jiaze, QIU Lihong, SHEN Weiting, CAI Mufa, LUO Wenying. Molecular epidemic characteristics of hypervirulent Klebsiella pneumoniae in Zhanjiang [J]. Laboratory Medicine, 2023, 38(11): 1026-1031. |
[8] | HU Shaohua, CHEN Li, ZHAO Meng, MA Zhan, ZHANG Hong. Epidemiological characteristic analysis of Mycoplasma pneumoniae infection in children in Shanghai [J]. Laboratory Medicine, 2023, 38(1): 14-17. |
[9] | WANG Su, DING Li, JIANG Wenrong, MIAO Yingxin, ZHANG Yanmei, ZHAO Hu. Research progress on drug resistance and treatment strategies of hypervirulent Klebsiella pneumoniae [J]. Laboratory Medicine, 2023, 38(1): 81-86. |
[10] | HUANG Yun, LI Congrong. Research progress on hypervirulent Klebsiella pneumonia [J]. Laboratory Medicine, 2021, 36(11): 1181-1185. |
[11] | ZHOU Yanxia, JIN Dongfang. Inhibition and mechanism of tannic acid on biofilm formation in Klebsiella pneumoniae [J]. Laboratory Medicine, 2021, 36(10): 1070-1073. |
[12] | XU Runhao, ZOU Chen, ZHANG Jie, LI Min, ZHANG Shulin. Application of serum bile acid spectrum in the differential diagnosis of pneumonia and lung cancer [J]. Laboratory Medicine, 2021, 36(1): 1-7. |
[13] | YANG Hongmei, TAO Jianmin, WEI Tian, WANG Jiangjun, MAO Jiahong, WANG Haiying. Incidenceand resistance profile of carbapenem-resistant Enterobacteriaceae among inpatients in a clinical center in Shanghai from 2015 to 2019 [J]. Laboratory Medicine, 2021, 36(1): 87-91. |
[14] | DU Jinlong, FENG Yan, LI Hengtao. Role of real-time fluorescence quantitative PCR-binding probe in the determination of MP and MP drug resistance [J]. Laboratory Medicine, 2020, 35(6): 535-539. |
[15] | ZHU Hong, ZHU Yuqing, GU Guobao. Role of PTX3 in the diagnosis of community-acquired pneumonia [J]. Laboratory Medicine, 2020, 35(5): 424-427. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||